Filters

Anti-IGF2BP1 siRNA

Anti-IGF2BP1 siRNA size: 30 nmol 717

Supplier ABBEX
Price 717
Size 30 nmol
CategorysiRNA
TargetIGF2BP1
ImmunogenSee techfile
Raised inSynthetic
Reactivity Mouse, Rat, Human
PurificationAffinity purified
ApplicationsWB (for other see techfile or inquire)
Stock availabilityShipped within 5-10 working days
Storage conditions Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C
WarningsThis product is for research use only
Gene targetIGF2BP1 siRNA
Short nameAnti-IGF2BP1 siRNA
Alternative nameantibody to-insulin-like growth factor 2 messenger RNA binding protein 1 small interfearing RNA
Alternative techniqueigfs
Alternative to gene target CRD-BP and CRDBP and IMP-1 and IMP1 and VICKZ1 and ZBP1, IGF2BP1 and IDBG-57431 and ENSG00000159217 and 10642, IGF2BP1 and IDBG-638842 and ENSBTAG00000011736 and 516853, Igf2bp1 and IDBG-209747 and ENSMUSG00000013415 and 140486, mRNA 5'-UTR binding, nuclei, this GO :0000166 and nucleotide binding and molecular function this GO :0003676 and nucleic acid binding and molecular function this GO :0003723 and RNA binding and molecular function this GO :0003729 and mRNA binding and molecular function this GO :0003730 and mRNA 3'-UTR binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006403 and RNA localization and biological process this GO :0010467 and gene expression and biological process this GO :0010494 and cytoplasmic stress granule and cellular component this GO :0010610 and regulation of mRNA stability involved in response to stress and biological process this GO :0017148 and negative regulation of translation and biological process this GO :0030027 and lamellipodium and cellular component this GO :0030175 and filopodium and cellular component this GO :0030424 and axon and cellular component this GO :0030425 and dendrite and cellular component this GO :0030426 and growth cone and cellular component this GO :0030529 and ribonucleoprotein complex and cellular component this GO :0042035 and regulation of cytokine biosynthetic process and biological process this GO :0043197 and dendritic spine and cellular component this GO :0044822 and poly(A) RNA binding and molecular function this GO :0045182 and translation regulator activity and molecular function this GO :0048027 and mRNA 5'-UTR binding and molecular function this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0051028 and mRNA transport and biological process this GO :0070934 and CRD-mediated mRNA stabilization and biological process this GO :0070937 and CRD-mediated mRNA stability complex and cellular component, this GO :0000166: nucleotide binding, this GO :0000166: nucleotide binding and also this GO :0003676: nucleic acid binding and also this GO :0003723: RNA binding and also this GO :0003729: mRNA binding and also this GO :0003730: mRNA 3'-UTR binding and also this GO :0005515: protein binding and also this GO :0044822: poly(A) RNA binding and also this GO :0045182: translation regulator activity and also this GO :0048027: mRNA 5'-UTR binding, this GO :0003676: nucleic acid binding, this GO :0003723: RNA binding, this GO :0003729: mRNA binding, this GO :0003730: mRNA 3'-UTR binding, this GO :0005515: protein binding, this GO :0044822: poly(A) RNA binding, this GO :0045182: translation regulator activity, this GO :0048027: mRNA 5'-UTR binding, insulin-like growth factor 2 mRNA binding protein 1
Identity 28866
Gene IGF2BP1
Long gene name insulin like growth factor 2 mRNA binding protein 1
Synonyms gene name insulin-like growth factor 2 mRNA binding protein 1
Synonyms IMP-1
Synonyms name IGF II mRNA binding protein 1
Locus 17q21, 32
Discovery year 2006-02-09
GenBank acession AF198254
Entrez gene record 10642
Pubmed identfication 9891060 11992722
RefSeq identity NM_006546
Classification RNA binding motif containing
Havana BLAST/BLAT OTTHUMG00000161173

Subscribe to our Newsletter